• Теги
    • избранные теги
    • Компании2210
      • Показать ещё
      • Показать ещё
      Международные организации51
      • Показать ещё
      Страны / Регионы526
      • Показать ещё
      • Показать ещё
      • Показать ещё
      • Показать ещё
21 июля, 18:45

Is a Beat in the Cards for ImmunoGen (IMGN) in Q2 Earnings?

ImmunoGen has made significant progress with its ovarian cancer pipeline candidate. Let's see if the company can come up with a beat this earnings season.

Выбор редакции
Выбор редакции
21 июля, 15:11

How Stephen Roche ruled cycling in 1987 | Steven Pye

Stephen Roche matched the great Eddy Merckx 30 years ago when he won the Giro d’Italia, Tour de France and World Championships in the same seasonBy Steven Pye for That 1980s Sports Blog, part of the Guardian Sport NetworkWhat is the favourite year of your life? I imagine the answer comes quicker for athletes than for us mere mortals. Steffi Graf may well say 1988, the year she pulled off her Golden Slam; Dennis Taylor would surely pick 1985; Andrew Flintoff would have to go for 2005; and Kelly Holmes would choose 2004. If you asked Irish cyclist Stephen Roche, surely he would say 1987.Roche changed my perception of the sport of cycling in 1987. When I was growing up in the 1980s, cycling mainly conjured up images of Kevin Keegan on Superstars. The nearest exposure I had to serious cycling was when I spent an interminable amount of time trying to win the Milk Race on my Spectrum 48K. Then along came Roche. Continue reading...

20 июля, 13:53

Tour de France 2017: Warren Barguil wins stage 18 as Froome maintains his lead – live!

Annemiek van Vleuten wins La Course stage oneThe Recap: the best of our coverage in your inbox each Friday 5.06pm BST Related: Tour de France 2017: Warren Barguil wins stage 18 as Froome maintains his lead – live! 5.01pm BST That’s all for today: Thanks for your time, your emails (sorry I couldn’t use them all) and your companyy on what was an eventful day’s racing, from the women’s La Course all the way through to the conclusion of Stage 18 of Le Tour. There’ll be somebody else in the hotseat tomorrow, but make sure to tune in. If the good lord spares me, I’ll be back on Saturday for what Lizzie Deignan, runner-up in La Course, called “that thing” followed by the penultimate stage of the men’s race. Continue reading...

Выбор редакции
19 июля, 17:17

11 Skin Care Products That Can Reverse Sun Damage

Staying out in the sun all day might feel nice, but it really does a number on your skin. But never fear! These products can help.

Выбор редакции
19 июля, 17:12

China slashes prices of patented western drugs by up to 70%

Medicines from Roche, GSK and Novartis now eligible for government insurance scheme

19 июля, 16:52

Can Biogen (BIIB) Keep the Earnings Streak Alive in Q2?

At Biogen's (BIIB) Q2 call, investor focus will remain on Tecfidera's scrip trends, pipeline progress and acquisition plans. All eyes will also be on Spinraza's performance in Q2.

19 июля, 13:17

Tour de France: Primoz Roglic wins stage 17 as Froome extends lead – live!

Green jersey Marcel Kittel abandons after early group crashMatthews wins chaotic stage 16 after ‘attacking like a maniac’Email Barry or tweet @bglendenning with your thoughts 4.35pm BST 4.31pm BST 1. Chris Froome 2. Rigoberto Uran +27sec 3. Romain Bardet 4. Fabio Aru, +53sec 5. Mikel Landa +1min 24sec Continue reading...

19 июля, 01:10

Puma's (PBYI) Breast Cancer Drug Neratinib Gets FDA Approval

Puma Biotechnology, Inc's (PBYI) lead breast cancer candidate neratinib is approved by FDA and is set to be commercially available in September under the brand name, Nerlynx.

18 июля, 16:46

Novartis Tops Q2 Earnings, Sandoz Faces Pricing Pressure

Novartis AG (NVS) reported second-quarter 2017 core earnings of $1.22 per share, beating the Zacks Consensus Estimate of $1.16 but the recorded figure was a penny lower than the year-ago figure of $1.23.

18 июля, 16:30

The Zacks Analyst Blog Highlights: Infosys, Toyota Motor, Honda Motor, Taiwan Semiconductor Manufacturing and Roche Holdings

The Zacks Analyst Blog Highlights: Infosys, Toyota Motor, Honda Motor, Taiwan Semiconductor Manufacturing and Roche Holdings

18 июля, 00:47

AstraZeneca (AZN) CEO Rumor Reportedly Ends, Shares Rise

AstraZeneca plc shares rose after the company reportedly confirmed that its CEO is not quitting the company to join the generic drug-maker, Teva Pharmaceutical Industries Limited (TEVA).

17 июля, 18:00

Mylan's Biosimilar Herceptin Gets FDA Advisory Committee Nod

Mylan N.V. (MYL) and partner, Biocon Ltd. announced that the FDA Oncologic Drugs Advisory Committee (ODAC) unanimously recommended approval of its biosimilar version of Roche's (RHHBY) breast cancer drug Herceptin (trastuzumab).

Выбор редакции
16 июля, 14:38

Tour de France 2017: Mollema wins stage 15 as Froome retains yellow jersey – as it happened

A storming, aggressive ride from Bauke Mollema gave him his first stage victory, while Chris Froome just about retained the yellow jersey after suffering a puncture at a particularly inopportune moment 5.03pm BST So thanks all for your company - enjoy the rest of the weekend. Bye! 5.01pm BST So, that was a pretty nifty day of behaviour. Barguil and Bardet properly put it in, but winners are Mollema, who rode brilliantly and aggressively all day to snaffle his first stage win ... and Chris Froome, just about. He survived a puncture at a terrible time and retains the yellow jersey; the question now is how much the battle back to out of his legs, especially given how tight it is at the top. We’ll find out on Tuesday, after a rest tomorrow - do join us for that. Continue reading...

15 июля, 13:40

Tour de France: Chris Froome back in yellow as Michael Matthews wins stage 14 – live!

Chris Froome back in yellow as Michael Matthews wins in Rodez 5.02pm BST 5.00pm BST Marooned at the back of the peloton without team-mates in the closing stages, Fabio Aru lost touch with the Big Boys and Sky took full advantage of his misfortune to take 25 seconds out of the Italian. On ITV, Chris Boardman has no sympathy whatsoever for Aru, saying today’s turn of events “was totally foreseeable and his team failed to foresee it”. He goes on to say he expects better from a major international cycling team with a multi-million pound budget. Continue reading...

Выбор редакции
14 июля, 14:40

Tour de France: Warren Barguil wins stage 13 on Bastille Day – live!

Warren Barguil wins the 101km stage from Saint-Girons to FoixFabio Aru in yellow jersey as Chris Froome stumbles on stage 12Email Barry or tweet @bglendenning with your thoughts 4.28pm BST Top-10 on Stage 13 #TDF2017 pic.twitter.com/L5aq9iYDlY 4.26pm BST Aru stays in yellow: The Italian Astana rider will stay in yellow as he finishes just behind Chris Froome, 1min 48sec behind Barguil. Continue reading...

14 июля, 01:11

Why Are Shares of Exelixis (EXEL) Up 77% So Far in 2017?

Shares of Exelixis, Inc. (KITE) have gained almost 4.68% on Aug 12. The company's shares have rallied a whopping 77% this year so far, outperforming the 7.8% increase registered by the Zacks categorized industry during this period.

14 июля, 00:37

Clovis (CLVS) Focuses on Rubraca Launch and Label Expansion

We issued an updated research report on Boulder, CO-based Clovis Oncology, Inc. (CLVS) on Jul 12.